Bioprocessing of recombinant proteins from Escherichia coli inclusion bodies: insights from structure-function relationship for novel applications
Authors:
- 19 December 2022
- journal article
- research article
- Published by Taylor & Francis in Preparative Biochemistry & Biotechnology
- Vol. 53 (7) , 728-752
Abstract
The formation of inclusion bodies (IBs) during expression of recombinant therapeutic proteins using E. coli is a significant hurdle in producing high-quality, safe, and efficacious medicines. The improved understanding of the structure-function relationship of the IBs has resulted in the development of novel biotechnologies that have streamlined the isolation, solubilization, refolding, and purification of the active functional proteins from the bacterial IBs. Together, this overall effort promises to radically improve the scope of experimental biology of therapeutic protein production and expand new prospects in IBs usage. Notably, the IBs are increasingly used for applications in more pristine areas such as drug delivery and material sciences. In this review, we intend to provide a comprehensive picture of the bio-processing of bacterial IBs, including assessing critical gaps that still need to be addressed and potential solutions to overcome them. We expect this review to be a useful resource for those working in the area of protein refolding and therapeutic protein production.Keywords
Funding Information
- Indian Institute of Technology (IIT(BHU)/Budget/19-(14)/2021-22/0975)
This publication has 223 references indexed in Scilit:
- Localization of Protein Aggregation in Escherichia coli Is Governed by Diffusion and Nucleoid Macromolecular Crowding EffectPLOS Computational Biology, 2013
- Kinetics of Inclusion Body Formation and Its Correlation with the Characteristics of Protein Aggregates in Escherichia coliPLOS ONE, 2012
- Strategies for production of active eukaryotic proteins in bacterial expression systemAsian Pacific Journal of Tropical Biomedicine, 2012
- Packaging protein drugs as bacterial inclusion bodies for therapeutic applicationsMicrobial Cell Factories, 2012
- Isolation of cell-free bacterial inclusion bodiesMicrobial Cell Factories, 2010
- Quality control of inclusion bodies in Escherichia coliMicrobial Cell Factories, 2010
- A novel Ecotin-Ubiquitin-Tag (ECUT) for efficient, soluble peptide production in the periplasm of Escherichia coliMicrobial Cell Factories, 2009
- Extrinsic Fluorescent Dyes as Tools for Protein CharacterizationPharmaceutical Research, 2008
- Is any measurement method optimal for all aggregate sizes and types?The AAPS Journal, 2006
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006